These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28224364)

  • 1. The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.
    Jones MS; Jones PC; Stern SL; Elashoff D; Hoon DSB; Thompson J; Mozzillo N; Nieweg OE; Noyes D; Hoekstra HJ; Zager JS; Roses DF; Testori A; Coventry BJ; Smithers MB; Andtbacka R; Agnese D; Schultz E; Hsueh EC; Kelley M; Schneebaum S; Jacobs L; Bowles T; Kashani-Sabet M; Johnson D; Faries MB
    Ann Surg Oncol; 2017 Aug; 24(8):2089-2094. PubMed ID: 28224364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
    Cochran AJ; Wen DR; Huang RR; Abrishami P; Smart C; Binder S; Scolyer RA; Thompson JF; Stern S; Van Kreuningen L; Elashoff DE; Sim MS; Wang HJ; Faries MB;
    Eur J Surg Oncol; 2022 Jun; 48(6):1280-1287. PubMed ID: 35246348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transected thin melanoma: Implications for sentinel lymph node staging.
    Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
    J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup.
    Ribero S; Osella-Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P
    Ann Surg Oncol; 2016 May; 23(5):1708-15. PubMed ID: 26597362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
    Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
    World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of sentinel lymph node diameter with melanoma metastasis.
    Merkow J; Paniccia A; Jones E; Jones T; Hodges M; Stovall R; Kounalakis N; Gajdos C; Lewis K; Robinson W; Gonzalez R; Pearlman N; McCarter M
    Am J Surg; 2016 Aug; 212(2):315-20. PubMed ID: 26827186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results.
    Vuylsteke RJ; van Leeuwen PA; Statius Muller MG; Gietema HA; Kragt DR; Meijer S
    J Clin Oncol; 2003 Mar; 21(6):1057-65. PubMed ID: 12637471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the positive sentinel lymph node in the post-MSLT-II era.
    Bredbeck BC; Mubarak E; Zubieta DG; Tesorero R; Holmes AR; Dossett LA; VanKoevering KK; Durham AB; Hughes TM
    J Surg Oncol; 2020 Dec; 122(8):1778-1784. PubMed ID: 32893366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
    Morton DL; Thompson JF; Essner R; Elashoff R; Stern SL; Nieweg OE; Roses DF; Karakousis CP; Mozzillo N; Reintgen D; Wang HJ; Glass EC; Cochran AJ
    Ann Surg; 1999 Oct; 230(4):453-63; discussion 463-5. PubMed ID: 10522715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
    Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    Ann Surg Oncol; 2018 Feb; 25(2):356-377. PubMed ID: 29236202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound.
    Keller J; Stern S; Chang SC; Marcus R; Weiss J; Nassoiy S; Christopher W; Fischer T; Essner R
    Ann Surg Oncol; 2022 Dec; 29(13):8469-8477. PubMed ID: 35989390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.